SCHEMBL257429

SCHEMBL257429

CC1C=CSC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16574358 1.00
SCHEMBL13604026 1.00
SCHEMBL3149039 0.65
SCHEMBL15016135 0.62
SCHEMBL13494677 0.62
SCHEMBL19441185 0.59
SCHEMBL10296442 0.59
SCHEMBL17461812 0.59
SCHEMBL10296429 0.59
SCHEMBL5822385 0.57

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 102 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114502677-B Black particles, black paint, coating film, and black matrix for color filter 积水化学工业株式会社 2023-11-14 CN disclosed
WO-2023009754-A2 PROTEIN-ANTIVIRAL COMPOUND CONJUGATES REGENERON PHARMACEUTICALS, INC. (US) 2023-02-02 WO disclosed
US-11513118-B2 Temporal thermal sensing and related methods C2Sense, Inc. (US) 2022-11-29 US disclosed
CN-114502677-A Black particles, black paint, coating film and black matrix for color filter 积水化学工业株式会社 2022-05-13 CN disclosed
US-20220145339-A1 METHOD FOR PREPARATION OF PRIMARY AMINE COMPOUNDS MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V. (DE) 2022-05-12 US disclosed
EP-3444245-B1 HETEROCYCLIC COMPOUND SUMITOMO CHEMICAL CO (JP) 2022-02-23 EP disclosed
EP-3371196-B1 HETEROCYCLIC COMPOUNDS AS INHIBITORS OF PLATELET AGGREGATION UNIV MONTREAL (CA) 2021-10-27 EP disclosed
US-20210116378-A1 TEMPORAL THERMAL SENSING AND RELATED METHODS C2Sense, Inc. (US) 2021-04-22 US disclosed
CN-110407854-B Novel tetracyclic compounds 北京加科思新药研发有限公司 2020-09-15 CN disclosed
WO-2020120420-A1 METHOD FOR PREPARATION OF PRIMARY AMINE COMPOUNDS MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2020-06-18 WO disclosed
US-20070213326-A1 SUBSTITUTED INDOLE COMPOUNDS AND THEIR USE AS 5-HT6 RECEPTOR MODULATORS LABORATORIOS DEL DR. ESTEVE S.A. (ES) 2007-09-13 US disclosed
US-20070213326-A1 SUBSTITUTED INDOLE COMPOUNDS AND THEIR USE AS 5-HT6 RECEPTOR MODULATORS LABORATORIOS DEL DR. ESTEVE S.A. (ES) 2007-09-13 US disclosed
US-RE39754-E1 Benzamide derivatives and pharmaceutical compositions containing same SCHERING AG (DE) 2007-07-31 US disclosed
US-7226929-B2 Pyrrolidin-2-one derivatives as inhibitors of factor xa SMITHKLINE BEECHAM CORPORATION (US) 2007-06-05 US disclosed
WO-2007060028-A1 NAPTHYRIDINE COMPOUNDS AS ROCK INHIBITORS GPC BIOTECH AG (DE) 2007-05-31 WO disclosed
EP-1757607-A1 N5-substituted benzo¬2,3|azepino¬4,5-b|indol-6-ones for treating tropical diseases Molisa GmbH (DE) 2007-02-28 EP disclosed
CN-1917849-A Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof PROCTER & GAMBLE (US) 2007-02-21 CN disclosed
US-20070032478-A1 Kinase Inhibitors ALLERGAN, INC. 2007-02-08 US disclosed
WO-2005023818-A2 HETEROBICYCLIC COMPOUNDS AS PHARMACEUTICALLY ACTIVE AGENTS GPC BIOTECH AG (DE) 2005-03-17 WO disclosed
EP-0847992-B1 Benzamide derivatives, useful as cell differentiation inducers SCHERING AG (DE) 2004-06-23 EP disclosed